Plasma microRNA signatures to predict EGFR-TKI resistance in EGFR-mutant advanced NSCLC patients.

被引：0
|
作者：
Wang, Shuhang
Wang, Jie
Bai, Hua
An, Tongtong
Zhao, Jun
Wang, Zhijie
Duan, Jianchun
Zhuo, Minglei
Wang, Yuyan
Wu, Meina
机构：
[1] Beijing Canc Hosp, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
[2] Peking Univ, Canc Hosp, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China
[3] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19136
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cytoplasmic ERβ expression to predict efficacy and survival of EGFR-TKI in EGFR-mutant NSCLC
    Wang, Zhijie
    Wang, Jie
    Wang, Xiaodong
    Shen, Zhirong
    Ding, Xiaosheng
    Bai, Hua
    Duan, Jianchun
    An, Tongtong
    Wang, Yuyan
    Zhuo, Minglei
    Wang, Shuhang
    Wu, Meina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Predicting duration of response to EGFR TKI among EGFR-mutant NSCLC patients.
    Sakr, Lama
    Kasymjanova, Goulnar
    Small, David I.
    Cohen, Victor
    Galvis, Luisa
    Pepe, Carmela
    Agulnik, Jason Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Transglutaminase 2(TG2) induces the intrinsic EGFR-TKI resistance in EGFR-mutant NSCLC
    Choi, Junyoung
    Yang, Hannah
    Kim, Sang-We
    Jung, Kyung Hae
    Park, Kang-Seo
    Lee, Dae Ho
    [J]. CANCER RESEARCH, 2017, 77
  • [4] Sequential administration of EGFR-TKI and pemetrexed achieved a long period of response in advanced NSCLC patients with EGFR-mutant tumors
    Chen, Y-Y.
    Zhu, Q-Q.
    Dai, L-J.
    Ding, Z-Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [5] Immunomodulatory Effects of Afatinib and Pembrolizumab in EGFR-Mutant NSCLC with Progression on Prior EGFR-TKI
    Riess, J.
    Kelly, K.
    Schalper, K.
    Shimoda, M.
    Lim, S.
    Monjazeb, A.
    Danenberg, K.
    Moore, E.
    Beckett, L.
    Mack, P.
    Maverakis, E.
    Gandara, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S528 - S528
  • [6] A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
    Song, Jiangdian
    Shi, Jingyun
    Dong, Di
    Fang, Mengjie
    Zhong, Wenzhao
    Wang, Kun
    Wu, Ning
    Huang, Yanqi
    Liu, Zhenyu
    Cheng, Yue
    Gan, Yuncui
    Zhou, Yongzhao
    Zhou, Ping
    Chen, Bojiang
    Liang, Changhong
    Liu, Zaiyi
    Li, Weimin
    Tian, Jie
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (15) : 3583 - 3592
  • [7] The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
    Lu, S.
    Wang, Q.
    Zhang, G.
    Dong, X.
    Yang, C.
    Song, Y.
    Chang, G.
    Lu, Y.
    Pan, H.
    Chiu, C.
    Wang, Z.
    Feng, J.
    Zhou, J.
    Xu, X.
    Guo, R.
    Chen, J.
    Yang, H.
    Chen, Y.
    Yu, Z.
    Shiah, H.
    Wang, C.
    Yang, N.
    Fang, J.
    Wang, P.
    Wang, K.
    Hu, Y.
    He, J.
    Wang, Z.
    Shi, J.
    Chen, S.
    Cheng, Y.
    Su, W.
    Hsia, T.
    Cui, J.
    Sun, Y.
    Yang, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S208 - S209
  • [8] Efficacy of immune checkpoint inhibitors in EGFR-Mutant NSCLC patients with EGFR-TKI resistance: A systematic review and meta-analysis
    Qian, Xiaoyu
    Guo, Xiaodan
    Li, Ting
    Hu, Wei
    Zhang, Lin
    Wu, Caisheng
    Ye, Feng
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma
    Tseng, Jeng-Sen
    Yang, Tsung-Ying
    Tsai, Chi-Ren
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Tsai, Meen-Hsin
    Yu, Sung-Liang
    Su, Kang-Yi
    Chen, Jeremy J. W.
    Chang, Gee-Chen
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 603 - 610
  • [10] Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
    Wenxian Wang
    Hong Wang
    Peihua Lu
    Zongyang Yu
    Chunwei Xu
    Wu Zhuang
    Zhengbo Song
    [J]. Journal of Translational Medicine, 17
12345